glp 1 agonist for pcos The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Superior metabolic improvement of polycystic

There is an FDA-approved generic version of Byetta (exenatide), which is used to treat Type 2 diabetes

32 , 46 Additional studies are required to draw conclusions for best practices to preserve muscle mass for patients taking GLP-1 agonist medications, however consistent resistance training and high protein diets should be considered until further studies are completed

In their meta-analysis, Monami et al also considered the occurrence of any major cardiovascular event, a composite end point of CV death, stroke, nonfatal myocardial infarction, heart failure, or acute coronary syndrome

The starting dose is typically 0.25 mg once weekly, which over time can be steadily increased

In those with T2DM who continue to have an A1C above target despite dual/triple therapy with metformin and other antidiabetic agents, the GLP-1 receptor agonists and dual agonists are preferred injectable medications to insulin due to similar or even better efficacy in A1C reduction, lower risk of hypoglycemia, and cardiovascular and renal protective benefits